Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 51-100 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT07219680
Intervention for Communication Quality of Life in Primary Progressive Aphasia
NARecruiting
25 participants
Started: Jan 3, 2026 · Completed: Aug 31, 2027
12 conditions3 sponsors1 location
NCT06854380
Effect of Intralesional Injection of Corticosteroids Combined with Hyaluronidase in Treatment of Minimal Associated Pathological Lesions of Vocal Folds, Participants and Condition: Patients with Benign Vocal Fold Lesions, Intervention: Intralesional Injection Via Working Channel of Nasofiberscope
EARLY_PHASE1Recruiting
20 participants
Started: Jan 1, 2026 · Completed: Oct 1, 2026
1 condition1 sponsor1 location
NCT06462092
Sacituzumab Govitecan and Intrathecal Chemotherapy for Treating Leptomeningeal Metastases From Her2-negative Breast Cancer
PHASE1/PHASE2Recruiting
34 participants
Started: Jan 1, 2026 · Completed: Jun 15, 2027
1 condition1 sponsor1 location
NCT06700356
Thalamus Seizure Detection With a Deep Brain Stimulator System
NARecruiting
5 participants
Started: Jan 1, 2026 · Completed: May 31, 2027
1 condition1 sponsor1 location
NCT07137936
Cardiac Magnetic Resonance - PROgnostic HEart Scar for Sudden Cardiac Death Prediction StudY
N/ARecruiting
1,000 participants
Started: Jan 1, 2026 · Completed: Dec 31, 2036
3 conditions1 sponsor1 location
NCT06940908
Living With Guillain-Barré Syndrome as Children.
N/ARecruiting
25 participants
Started: Jan 1, 2026 · Completed: Jun 1, 2027
2 conditions1 sponsor2 locations
NCT05018858
Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for Lupus
PHASE1Recruiting
15 participants
Started: Dec 31, 2025 · Completed: Oct 31, 2028
1 condition1 sponsor2 locations
NCT07209462
Study of MRM-3379 in Male Participants With Fragile X Syndrome
PHASE2Recruiting
60 participants
Started: Dec 31, 2025 · Completed: Oct 31, 2027
1 condition1 sponsor5 locations
NCT05837221
Microbiome in Head and Neck Squamous Cell Carcinoma
N/ARecruiting
60 participants
Started: Dec 31, 2025 · Completed: Jan 31, 2030
4 conditions2 sponsors1 location
NCT06856499
Cirtuvivint/Olaparib in Breast Cancer Susceptibility Gene/Homologous Recombination Deficiency Platinum Resistant Ovarian Cancer
PHASE1Recruiting
50 participants
Started: Dec 31, 2025 · Completed: Jul 31, 2029
3 conditions3 sponsors2 locations
NCT06511999
Continuous Jugular Venous Oxygen Saturation (SjO2) Measurement After Cardiac Arrest
N/ARecruiting
25 participants
Started: Dec 31, 2025 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT05183048
Comparison of 89Zr Panitumumab and (18)F-Fluorodeoxyglucose to Identify Head and Neck Squamous Cell Carcinoma
EARLY_PHASE1Recruiting
14 participants
Started: Dec 31, 2025 · Completed: Mar 31, 2026
1 condition1 sponsor1 location
NCT05199688
A Study To Evaluate Pharmacokinetics, Efficacy, Safety, Tolerability, And Pharmacodynamics Of Satralizumab In Pediatric Patients With Aquaporin-4 Antibody Positive Neuromyelitis Optica Spectrum Disorder (NMOSD)
PHASE3Recruiting
8 participants
Started: Dec 31, 2025 · Completed: Sep 12, 2029
2 conditions1 sponsor10 locations
NCT06863311
Trial of XL092 in Combination With Immunotherapy in Patients Who Progress on Adjuvant Therapy in Clear Cell RCC
PHASE2Recruiting
70 participants
Started: Dec 31, 2025 · Completed: Dec 31, 2028
3 conditions3 sponsors1 location
NCT07185997
Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations
PHASE3Recruiting
480 participants
Started: Dec 31, 2025 · Completed: Dec 31, 2030
6 conditions1 sponsor1 location
NCT06741618
MyPEEPS Mobile Plus: A Multi-Level HIV Prevention Intervention for Young MSM
NARecruiting
500 participants
Started: Dec 31, 2025 · Completed: Dec 31, 2029
1 condition4 sponsors1 location
NCT04175938
Assessment of Corneal Endothelial Function Following Hypoxic Stress
PHASE1/PHASE2Recruiting
20 participants
Started: Dec 31, 2025 · Completed: Nov 30, 2027
1 condition1 sponsor1 location
NCT07001241
Telehealth Exercise Program Evaluating Fatigue and Physical Function in Rural Cancer Survivors
PHASE2Recruiting
134 participants
Started: Dec 31, 2025 · Completed: Dec 31, 2030
3 conditions2 sponsors2 locations
NCT07058155
Optimizing Portal Hypertension With TIPS and Interval Metabolic Surgery for Advanced Liver Disease
PHASE4Recruiting
70 participants
Started: Dec 31, 2025 · Completed: Feb 1, 2034
4 conditions2 sponsors1 location
NCT07125183
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
PHASE2Recruiting
20 participants
Started: Dec 31, 2025 · Completed: Dec 31, 2029
1 condition2 sponsors1 location
NCT07052370
TCRαβ-depleted Progenitor Cell Graft With Early Memory T-cell DLI, Plus Selected Use of Blinatumomab, in naïve T-cell Depleted Haploidentical Donor Hematopoietic Cell Transplantation for Hematologic Malignancies
PHASE1Recruiting
30 participants
Started: Dec 31, 2025 · Completed: Dec 31, 2030
1 condition1 sponsor1 location
NCT07033416
A Trial Of Approach Bias Modification Training During Treatment For Cocaine Use Disorder
NARecruiting
60 participants
Started: Dec 31, 2025 · Completed: Oct 1, 2026
1 condition2 sponsors1 location
NCT07085338
A Phase II Study With a Safety Run-In of the Addition of N-803 to a Chemoimmunotherapy Backbone for the Treatment of Patients With Relapsed or Refractory Neuroblastoma
PHASE2Recruiting
54 participants
Started: Dec 31, 2025 · Completed: Feb 1, 2029
1 condition1 sponsor1 location
NCT07109791
National Surveillance and Prevention of Neonatal VAP
N/ARecruiting
1,500 participants
Started: Dec 31, 2025 · Completed: Sep 30, 2029
4 conditions5 sponsors1 location
NCT07153536
Spinal Cord Stimulation Combined With Physical Therapy in Post-Stroke Upper-Limb Motor Hemiparesis
NARecruiting
15 participants
Started: Dec 31, 2025 · Completed: Jan 31, 2028
3 conditions3 sponsors1 location
NCT01037387
Effect of Noninvasive Ventilation on Physical Activity and Inflammation in COPD Patients
PHASE4Recruiting
50 participants
Started: Dec 31, 2025 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT07084129
Vancomycin and Acute Kidney Injury in Sepsis Treatment - Intervention
PHASE1Recruiting
20 participants
Started: Dec 31, 2025 · Completed: Dec 31, 2026
1 condition2 sponsors1 location
NCT06701812
Digoxin Medulloblastoma Study
PHASE2Recruiting
23 participants
Started: Dec 31, 2025 · Completed: Feb 28, 2027
2 conditions2 sponsors14 locations
NCT07111039
Compare Airway Pressure Release Ventilation (APRV) to Conventional Mechanical Ventila
NARecruiting
12 participants
Started: Dec 31, 2025 · Completed: Jul 31, 2026
2 conditions1 sponsor1 location
NCT06712862
A Clinical Study of Evaluating Myocardial Viability in Ischemic Heart Disease with Integrated 18F-FDG PET/MR
N/ARecruiting
100 participants
Started: Dec 31, 2025 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT06903468
Novel Cavity Marking Technique in Breast Cancer Patients Undergoing Breast Conservation Surgery With Oncoplastic Reconstruction for the Delivery of Adjuvant Radiotherapy and Accuracy of Recommended Re-excisions
NARecruiting
50 participants
Started: Dec 31, 2025 · Completed: Nov 30, 2029
2 conditions1 sponsor1 location
NCT07154082
Apatinib Mesylate and Camrelizumab Combined With TACE as Neoadjuvant Therapy for Hepatocellular Carcinoma
PHASE2Recruiting
27 participants
Started: Dec 30, 2025 · Completed: Jul 31, 2028
1 condition1 sponsor1 location
NCT06593392
Safety and Tolerability of Difelikefalin in Adolescents on Haemodialysis With Moderate-to-Severe Pruritus
PHASE2Recruiting
18 participants
Started: Dec 29, 2025 · Completed: Aug 30, 2029
2 conditions1 sponsor1 location
NCT03676647
Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules
N/ARecruiting
22 participants
Started: Dec 25, 2025 · Completed: Sep 25, 2028
1 condition2 sponsors1 location
NCT05067998
The Benefits of Natural Medicine, Vitamin IV Therapy and Supplements: Maintaining Good Health Through Nature
N/ARecruiting
25 participants
Started: Dec 21, 2025 · Completed: Sep 17, 2026
5 conditions1 sponsor1 location
NCT06302296
Evaluating the Effect of Injectable Platelet-rich Fibrin on Accelerating Orthodontic Tooth Movement
NARecruiting
14 participants
Started: Dec 20, 2025 · Completed: Jul 15, 2026
2 conditions1 sponsor1 location
NCT06823037
Hormonal Contraception Access Through Pharmacist Prescribing Implementation
NARecruiting
150 participants
Started: Dec 15, 2025 · Completed: Aug 31, 2026
4 conditions2 sponsors1 location
NCT06860815
Cemiplimab and Transarterial Radioembolization With Y-90 SIR-S Spheres for the Treatment of Liver Directed Metastatic Breast Cancer
PHASE2Recruiting
11 participants
Started: Dec 12, 2025 · Completed: Jan 3, 2027
3 conditions2 sponsors1 location
NCT06770023
Bridge to Lung Transplant With Trans-septal Extra-corporeal Membrane Oxygenation (ECMO) for Right Heart Failure From Pulmonary Hypertension
PHASE1Recruiting
4 participants
Started: Dec 11, 2025 · Completed: Dec 31, 2028
2 conditions1 sponsor1 location
NCT06707493
Ivosidenib as Post-HSCT Maintenance for AML
PHASE2Recruiting
75 participants
Started: Dec 8, 2025 · Completed: Jan 1, 2030
3 conditions2 sponsors2 locations
NCT07202247
Metabolic Interventions (Time-Restricted Eating, GLP1 Receptor Agonist, and Heart Healthy Diet) to Improve Cardiometabolic Health in Prostate Cancer Patients During Androgen Deprivation Therapy, IMPACT-ADT Trial
PHASE2Recruiting
60 participants
Started: Dec 8, 2025 · Completed: Apr 9, 2028
2 conditions2 sponsors1 location
NCT06552338
Wellness of Osteopathic Medical Students Throughout Their Training (Well-COM)
N/ARecruiting
650 participants
Started: Dec 7, 2025 · Completed: Dec 31, 2044
1 condition1 sponsor1 location
NCT06412120
Study Evaluating Safety, Tolerability, and Metabolism of Niraparib
PHASE4Recruiting
70 participants
Started: Dec 1, 2025 · Completed: Oct 1, 2030
1 condition2 sponsors1 location
NCT07030283
Intraperitoneal Paclitaxel With NALIRIFOX for Pancreatic Ductal Adenocarcinoma With Peritoneal Carcinomatosis
PHASE1Recruiting
10 participants
Started: Dec 1, 2025 · Completed: Jul 1, 2030
1 condition1 sponsor1 location
NCT06910124
Linvoseltamab in Addition to Lenalidomide (L2) During Maintenance Therapy of NDMM to Deepen Responses or Redrive MRD Negativity After Relapse
PHASE2Recruiting
32 participants
Started: Dec 1, 2025 · Completed: Dec 1, 2032
1 condition2 sponsors1 location
NCT06192329
Hot Water Therapy for the Treatment of Menopause-related Hot Flashes
NARecruiting
100 participants
Started: Dec 1, 2025 · Completed: May 1, 2026
3 conditions2 sponsors1 location
NCT06402955
Imaging Depression in Parkinson's Disease
PHASE2Recruiting
120 participants
Started: Dec 1, 2025 · Completed: Dec 31, 2029
2 conditions2 sponsors1 location
NCT07092527
Androgen Effects on the Reproductive Neuroendocrine Axis, 2025 Version
PHASE4Recruiting
80 participants
Started: Dec 1, 2025 · Completed: Nov 30, 2028
2 conditions3 sponsors1 location
NCT06793215
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
PHASE3Recruiting
600 participants
Started: Dec 1, 2025 · Completed: Oct 31, 2030
2 conditions2 sponsors10 locations
NCT06666712
Chronic CED of TPT for Recurrent Malignant Glioma
PHASE1Recruiting
6 participants
Started: Dec 1, 2025 · Completed: Jun 30, 2028
3 conditions1 sponsor1 location